Last updated on November 2019

Vyndaqel Capsules Special Investigation (ATTR-CM)


Brief description of study

Secondary Data Collection : To confirm the safety and effectiveness profiles under the actual medical practice of Vyndaqel in Japan.

Detailed Study Description

To comprehend information on the long-term safety (e.g., onset status of adverse reactions), etc. of patients who are treated with Vyndaqel for the treatment of transthyretin amyloid cardiomyopathy.

Clinical Study Identifier: NCT04108091

Find a site near you

Start Over

Pfizer

Tokyo, Japan
  Connect »